SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010431
Filing Date
2021-08-05
Accepted
2021-08-05 09:02:53
Documents
52
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q albo-20210630x10q.htm   iXBRL 10-Q 1343034
2 EX-31.1 albo-20210630xex31d1.htm EX-31.1 10375
3 EX-31.2 albo-20210630xex31d2.htm EX-31.2 10340
4 EX-32.1 albo-20210630xex32d1.htm EX-32.1 10538
  Complete submission text file 0001558370-21-010431.txt   4178791

Data Files

Seq Description Document Type Size
5 EX-101.SCH albo-20210630.xsd EX-101.SCH 30643
6 EX-101.CAL albo-20210630_cal.xml EX-101.CAL 32243
7 EX-101.DEF albo-20210630_def.xml EX-101.DEF 82272
8 EX-101.LAB albo-20210630_lab.xml EX-101.LAB 281738
9 EX-101.PRE albo-20210630_pre.xml EX-101.PRE 195785
10 EXTRACTED XBRL INSTANCE DOCUMENT albo-20210630x10q_htm.xml XML 526501
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 211146577
SIC: 2834 Pharmaceutical Preparations